Edition:
United States

United Therapeutics Corp (UTHR.O)

UTHR.O on Nasdaq

107.89USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$107.89
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
375,588
52-wk High
$152.55
52-wk Low
$100.57

Chart for

About

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH):... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $5,381.27
Shares Outstanding(Mil.): 43.44
Dividend: --
Yield (%): --

Financials

  UTHR.O Industry Sector
P/E (TTM): 14.44 69.71 34.39
EPS (TTM): 8.58 -- --
ROI: 20.98 9.01 14.96
ROE: 21.85 10.15 16.52

Arena Pharma soars on deal with United Therapeutics for hypertension drug

Shares of Arena Pharmaceuticals Inc jumped nearly 30 percent after the drug developer sold rights to develop and sell its hypertension treatment to United Therapeutics Corp, fetching it $800 million in an upfront payment.

Nov 15 2018

Earnings vs. Estimates